🔎 Trials Near Me

Home › Atherosclerosis › Colorado

Pag-aaral pangklinika para sa Atherosclerosis sa Colorado

6 pag-aaral para sa Atherosclerosis ang naghahanap ng mga kalahok sa mga site sa Colorado.

Mga Lungsod sa Colorado

Opisyal na teksto ng pag-aaral (English)

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

  • Lynn Institute of Denver, Aurora
  • University of Colorado Anschutz Medical Campus, Aurora
  • Legacy Clinical Trials, Colorado Springs
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07157774

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • Western Nephrology, Arvada
  • Kidney Associates of Colorado, P.C., Denver
  • Colorado Kidney Care, Denver
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Thornton
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT07000357

Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma

  • University of Colorado Hospital, Aurora
Nagre-recruit
Edad 55 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT07704918

Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic Cardiovascular Disease

  • University of Colorado Health System (UCHealth), Aurora
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 23, 2026 · NCT07334834

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

  • Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 17, 2025 · NCT02915198

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.